Plasmodium falciparum parasites lacking histidine-rich protein 2 and 3: A review and recommendations for accurate reporting

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Cheng, Qin ^a   Gatton, Michelle L ^b   Barnwell, John ^c   Chiodini, Peter ^d   McCarthy, James ^e   Bell, David ^f   Cunningham, Jane ^g  

^a AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

^e QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^f Independent Consultant   (Switzerland)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HISTIDINE-RICH PROTEINS; HRP-2 ANTIGEN, PLASMODIUM FALCIPARUM; HRP3 PROTEIN, PLASMODIUM FALCIPARUM; PARASITE ANTIGEN; PROTEIN; PROTOZOAL PROTEIN;

GENE DELETION; GENETICS; HUMAN; MALARIA, FALCIPARUM; PARASITOLOGY; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PROCEDURES;

ANTIGENS, PROTOZOAN; GENE DELETION; HUMANS; MALARIA, FALCIPARUM; PARASITOLOGY; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PROTEINS; PROTOZOAN PROTEINS;

EID: 84904530329     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-283     Document Type: Article

References (35)

1. WHO, World Malaria Report 2013 Geneva: World Health Organization 2013
2. WHO, Antimalarial drug combination therapy. Report of a WHO technical consultation Geneva: World Health Organization 2001
3. WHO, Guidelines for the treatment of malaria Geneva: World Health Organization 2 2010
4. Use of rapid diagnostic tests for diagnosis of malaria in the UK. Chilton D, Malik AN, Armstrong M, Kettelhut M, Parker-Williams J, Chiodini PL, J Clin Pathol 2006 59 862 866 (Pubitemid 44211750)
5. World Health Organization, World Malaria Report 2012 Geneva: World Health Organization 2012
6. WHO, Malaria rapid diagnostic test performance. Results of WHO product testing of malaria RDTs: Round 4 Geneva: World Health Organization 2012
7. Effect of sequence variation in Plasmodium falciparum histidine- rich protein 2 on binding of specific monoclonal antibodies: Implications for rapid diagnostic tests for malaria. Lee N, Baker J, Andrews KT, Gatton ML, Bell D, Cheng Q, McCarthy J, J Clin Microbiol 2006 44 2773 2778 (Pubitemid 44228570)
8. The heat stability of Plasmodium lactate dehydrogenase-based and histidine-rich protein 2-based malaria rapid diagnostic tests. Chiodini PL, Bowers K, Jorgensen P, Barnwell JW, Grady KK, Luchavez J, Moody AH, Cenizal A, Bell D, Trans R Soc Trop Med Hyg 2007 101 331 337 (Pubitemid 46205898)
9. WHO, Information note on recommended selection criteria for procurement of malaria rapid diagnostic tests (RDTs) Geneva: World Health Organization 2012 http://www.who.int/malaria/publications/atoz/rdt-selection-criteria/en/
10. Rapid diagnostic tests for diagnosing uncomplicated P. Falciparum malaria in endemic countries. Abba K, Deeks J, Olliaro P, Naing C, Jackson S, Takwoingi Y, Donegan S, Garner P, Cochrane Database Syst Rev 2011 6 D008122 doi:10.1002/1465 1858. CD008122. pub2
11. Laboratory demonstration of a prozone-like effect in HRP2-detecting malaria rapid diagnostic tests: implications for clinical management. Luchavez J, Baker J, Alcantara S, Belizario V Jr, Cheng Q, McCarthy JS, Bell D, Malar J 2011 10 286
12. Prozone in malaria rapid diagnostics tests: how many cases are missed? Gillet P, Scheirlinck A, Stokx J, De Weggheleire A, Chauque HS, Canhanga OD, Tadeu BT, Mosse CD, Tiago A, Mabunda S, Bruggeman C, Bottieau E, Jacobs J, Malar J 2011 10 166
13. Global sequence variation in the histidine-rich proteins 2 and 3 of Plasmodium falciparum: implications for the performance of malaria rapid diagnostic tests. Baker J, Ho MF, Pelecanos A, Gatton M, Chen N, Abdullah S, Albertini A, Ariey F, Barnwell J, Bell D, Cunningham J, Djalle D, Echeverry DF, Gamboa D, Hii J, Kyaw MP, Luchavez J, Membi C, Menard D, Murillo C, Nhem S, Ogutu B, Onyor P, Oyibo W, Wang SQ, McCarthy J, Cheng Q, Malar J 2010 9 129
14. Molecular karyotype of Plasmodium falciparum: conserved linkage groups and expendable histidine-rich protein genes. Kemp DJ, Thompson JK, Walliker D, Corcoran LM, Proc Natl Acad Sci U S A 1987 84 7672 7676
15. An RFLP map of the Plasmodium falciparum genome, recombination rates and favored linkage groups in a genetic cross. Walker JA, Dolan SA, Gwadz RW, Panton LJ, Wellems TE, Mol Biochem Parasitol 1992 51 313 320
16. Large deletions result from breakage and healing of P. Falciparum chromosomes. Pologe LG, Ravetch JV, Cell 1988 55 869 874
17. Cloning and characterization of chromosome breakpoints of Plasmodium falciparum: breakage and new telomere formation occurs frequently and randomly in subtelomeric genes. Scherf A, Mattei D, Nucleic Acids Res 1992 20 1491 1496
18. A histidine-rich protein gene marks a linkage group favored strongly in a genetic cross of Plasmodium falciparum. Wellems TE, Walliker D, Smith CL, do RV, Maloy WL, Howard RJ, Carter R, McCutchan TF, Cell 1987 49 633 642
19. A large proportion of P. Falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests. Gamboa D, Ho MF, Bendezu J, Torres K, Chiodini PL, Barnwell JW, Incardona S, Perkins M, Bell D, McCarthy J, Cheng Q, PLoS One 2010 5 8091
20. Genome scanning of Amazonian Plasmodium falciparum shows subtelomeric instability and clindamycin-resistant parasites. Dharia NV, Plouffe D, Bopp SE, Gonzalez-Paez GE, Lucas C, Salas C, Soberon V, Bursulaya B, Kochel TJ, Bacon DJ, Winzeler EA, Genome Res 2010 20 1534 1544
21. Multiple genetic origins of histidine-rich protein 2 gene deletion in Plasmodium falciparum parasites from Peru. Akinyi S, Hayden T, Gamboa D, Torres K, Bendezu J, Abdallah JF, Griffing SM, Quezada WM, Arrospide N, De Oliveira AM, Lucas C, Magill AJ, Bacon DJ, Barnwell JW, Udhayakumar V, Sci Rep 2013 3 2797
22. Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests. Baker J, McCarthy J, Gatton M, Kyle DE, Belizario V, Luchavez J, Bell D, Cheng Q, J Infect Dis 2005 192 870 877 (Pubitemid 41193085)
23. Rapid diagnostic tests for malaria diagnosis in the Peruvian Amazon: impact of pfhrp2 gene deletions and cross-reactions. Maltha J, Gamboa D, Bendezu J, Sanchez L, Cnops L, Gillet P, Jacobs J, PLoS One 2012 7 43094
24. Combined deletions of pfhrp2 and pfhrp3 genes result in Plasmodium falciparum malaria false-negative rapid diagnostic test. Houze S, Hubert V, Le Pessec G, Le Bras J, Clain J, J Clin Microbiol 2011 49 2694 2696
25. High performance of histidine-rich protein 2 based rapid diagnostic tests in French Guiana are explained by the absence of pfhrp2 gene deletion in P. Falciparum. Trouvay M, Palazon G, Berger F, Volney B, Blanchet D, Faway E, Donato D, Legrand E, Carme B, Musset L, PLoS One 2013 8 74269
26. False-negative rapid diagnostic tests for malaria and deletion of the histidine-rich repeat region of the hrp2 gene. Koita OA, Doumbo OK, Ouattara A, Tall LK, Konare A, Diakite M, Diallo M, Sagara I, Masinde GL, Doumbo SN, Dolo A, Tounkara A, Traore I, Krogstad DJ, Am J Trop Med Hyg 2012 86 194 198
27. Sequence variation does not confound the measurement of plasma PfHRP2 concentration in African children presenting with severe malaria. Ramutton T, Hendriksen IC, Mwanga-Amumpaire J, Mtove G, Olaosebikan R, Tshefu AK, Onyamboko MA, Karema C, Maitland K, Gomes E, Gesase S, Reyburn H, Silamut K, Chotivanich K, Promnares K, Fanello CI, von Seidlein L, Day NP, White NJ, Dondorp AM, Imwong M, Woodrow CJ, Malar J 2012 11 276
28. Pfhrp2 and pfhrp3 polymorphisms in Plasmodium falciparum isolates from Dakar, Senegal: impact on rapid malaria diagnostic tests. Wurtz N, Fall B, Bui K, Pascual A, Fall M, Camara C, Diatta B, Fall KB, Mbaye PS, Dieme Y, Bercion R, Wade B, Briolant S, Pradines B, Malar J 2013 12 34
29. Genetic deletion of HRP2 and HRP3 in Indian Plasmodium falciparum population and false negative malaria rapid diagnostic test. Kumar N, Pande V, Bhatt RM, Shah NK, Mishra N, Srivastava B, Valecha N, Anvikar AR, Acta Trop 2013 125 119 121
30. Establishment of the 1st World Health Organization International Standard for Plasmodium falciparum DNA for nucleic acid amplification technique (NAT)-based assays. Padley DJ, Heath AB, Sutherland C, Chiodini PL, Baylis SA, Malar J 2008 7 139
31. Community case management of fever due to malaria and pneumonia in children under five in Zambia: a cluster randomized controlled trial. Yeboah-Antwi K, Pilingana P, Macleod WB, Semrau K, Siazeele K, Kalesha P, Hamainza B, Seidenberg P, Mazimba A, Sabin L, Kamholz K, Thea DM, Hamer DH, PLoS Med 2010 7 1000340
32. Can treatment of malaria be restricted to parasitologically confirmed malaria? A school-based study in Benin in children with and without fever. Faucher JF, Makoutode P, Abiou G, Beheton T, Houze P, Ouendo E, Houze S, Deloron P, Cot M, Malar J 2010 9 104
33. Withholding antimalarials in febrile children who have a negative result for a rapid diagnostic test. d'Acremont V, Malila A, Swai N, Tillya R, Kahama-Maro J, Lengeler C, Genton B, Clin Infect Dis 2010 51 506 511
34. Treatment guided by rapid diagnostic tests for malaria in Tanzanian children: safety and alternative bacterial diagnoses. Mtove G, Hendriksen IC, Amos B, Mrema H, Mandia V, Manjurano A, Muro F, Sykes A, Hildenwall H, Whitty CJ, Reyburn H, Malar J 2011 10 290
35. Rapid diagnostic test-based management of malaria: an effectiveness study in Papua New Guinean infants with Plasmodium falciparum and Plasmodium vivax malaria. Senn N, Rarau P, Manong D, Salib M, Siba P, Robinson LJ, Reeder J, Rogerson S, Mueller I, Genton B, Clin Infect Dis 2012 54 644 651